28 Experiences of using Paxlovid to treat clinically extremely vulnerable non-hospitalised patients with COVID-19

• Joshua Gahir,
• Jasjot Saund,
• Michael Brown,
• Jatinder Harchowal,
• Laura Waters

Affiliations

Joshua Gahir

Division of Infection, University College London Hospital, London, United Kingdom; Corresponding author.

Jasjot Saund

Division of Infection, University College London Hospital, London, United Kingdom

Michael Brown

Division of Infection, University College London Hospital, London, United Kingdom

Jatinder Harchowal

Pharmacy Department, University College London Hospital, London, United Kingdom

Laura Waters

Department of HIV & Sexual Health, Central & North West London NHS Trust, London, United Kingdom; Division of Infection, University College London Hospital, London, United Kingdom